Levothyroxine Sodium Tablet
Product Images NDC 51655-583

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-583-52 (51655 583 52 Rev A 03 23)

Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.150 mg) oral tablets, packaged in a bottle containing 30 tablets. The label includes storage instructions, manufacturer Northwind Pharmaceuticals in Indianapolis, IN, and repackager information from Lannett Company, Inc. It states Rx Only and provides various codes including NDC 51655-583-52.*

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Chemical structure diagram of Levothyroxine Sodium showing its molecular components, including iodine atoms, hydroxyl group, ether linkage, and sodium carboxylate with water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.